Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients

Archives of Dermatology

Volumn 133, Issue 1, 1997, Pages 41-44

  Fujiwara, Hiroshi ^a,b,h   Fujiwara, Keiko ^a,b   Hashimoto, Ken ^a   Mehregan, Amir H ^a,c   Schaumburg Lever, Gundula ^d   Lange, Robert ^e   Schempp, Christoph ^f   Gollnick, Harald ^g  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIIGATA UNIVERSITY   (Japan)

^c Pinkus Dermatopathology Laboratory   (United States)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Immanuel Hospital   (Germany)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; CLINICAL ARTICLE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MORPHEA; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SKIN BIOPSY;

EID: 0031053567     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.1.41     Document Type: Article

References (23)

1. Åsbrink E, Hovmark A. Early and late cutaneous manifestations in lxoes-born borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann N Y Acad Sci 1988;539:4-15.
2. Ilowite NT. Muscle, reticuloendothelial and late stage skin manifestations of Lyme disease. Am J Med. 1995;98(suppl):63S-68S.
3. Hansen K, Serup J, Höybye S. Antibodies to Borrelia burgdorferi and localized scleroderma. Lancet. 1987;1:682.
4. Takahashi S, Niizaki H, Fukuda T, et al. Anti-Borrelia burgoorferi antibodies in the patients with localized scleroderma. Jpn J Dermatol. 1995;105:1301- 1307.
5. Buechner SA, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection. J Am Acad Dermatol. 1993;29:190-196.
6. Schempp C, Bocklage H, Lange R, Kölmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DMA amplification. J Invest Dermatol. 1993;100:717-720.
7. Marconi RT, Garon CF. Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol. 1992;30:2830-2834.
8. Fujiwara H, Hashimoto K, Fujiwara K, Mehregan AH. Detection of human immunodeficiency virus type 1 and human papillomavirus type 16 in acquired immunodeficiency syndrome-related and classic Kaposi's sarcoma. Arch Dermatol. 1993;129:1620-1622.
9. Fujiwara H, Fujiwara K, Yotsumoto S, Hashimoto K. Failure to detect paramyxovirus RNA in the skin of connective tissue disease. J Dermatol Sci. 1996;11:70-75.
10. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem. 1991;39:351-354.
11. Wallich R, Moter SE, Simon MM, Ebnet K, HeibergerA, Kramer MD. The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun. 1990;58:1711-1719.
12. Krüger WH, Pulz M. Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction. J Med Microbiol. 1991;35:98-102.
13. Bocklage H, Lange R, Karch H, Heesemann J, Kölmel HW. Nested polymerase chain reaction for the identification of B burgdorferi in the tertiary stage of neuroborreliosis. In: Rolfs A, Schuller I, Finckh U, Weber-Rolfs I, eds. PCR: Clinical Diagnostics and Research. Berlin, Germany: Springer-Verlag; 1992:A18-A21.
14. Kuiper H, Cairo I, van Dam A, et al. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br J Dermatol. 1994;130:466-472.
15. Kramer MD, Moter SE, Simon MM, Ebnet K, Wallich R, Die Polymerase- Kettenreaktion zum Nachweis von Borrelia-burgdorferi-DNS. Hautarzt. 1990;41:587-590.
16. Berg D, Abson KG, Prose NS. The laboratory diagnosis of Lyme disease. Arch Dermatol. 1991;127:866-870.
17. Meis JF, Koopman R, van Bergen B, Pool G, Melchers W. No evidence for relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Arch Dermatol. 1993;129:386-387.
18. Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol. 1994;102:339-345.
19. Wienecke R, Schlüpen E-M, Zöling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol. 1995;104:23-26.
20. Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol. 1995;33:617-620.
21. Fan W, Leonard CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). Am J Acad Dermatol. 1995;33:682- 684.
22. Nakao M, Miyamoto K, Fukunaga M. Lyme disease spirochetes in Japan: enzootic transmission cycles in birds, rodents, and Ixodes persulcatus ticks. J Infect Dis. 1994;170:878-882.
23. Schempp C, Owsianowski M, Lange R, Gollnick H. Comparison of Borrelia burgdorferi ultrasonicate and whole B burgdorferi cells as a stimulus for T-cell proliferation and GM-CSF secretion in vitro. Zentralbl Bacteriol. 1993;279:417- 425.